임상시험 트래커
추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov
기업
36건 표시
- 2상모집 예정· Antibody-Mediated Rejection (AMR)A Study of Mezagitamab in Adults With Late Antibody-Mediated Rejection (AMR) After a Kidney Transplant
리드: 다케다
- 2상모집 예정· Crohn's DiseaseA Study of Zasocitinib (TAK-279) in Adults With Active Crohn's Disease
리드: 다케다
- 2상모집 중· Narcolepsy Type 1A Study of TAK-360 in Adults With Narcolepsy Type 1 (Narcolepsy With Cataplexy)
리드: 다케다
- 2상모집 중· Myelodysplastic SyndromesA Study of TAK-226 for Anemia in Japanese Patients With Lower-Risk Myelodysplastic Syndromes
리드: 다케다
- 2상모집 중· B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1Dose-Adjusted EPOCH With or Without Rituximab Plus Ponatinib for the Treatment of Newly-Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia/Lymphoma
협력: 다케다
- 2상모집 중· Metastatic Colorectal Cancer (CRC)Trial of 5-Fluorouracil (5FU)-Based Therapy in Combination With Fruquintinib in Patients With Locally Advanced Unresectable or Metastatic Colorectal Cancer
협력: 다케다
- 2상모집 중· Hidradenitis SuppurativaA Study of Zasocitinib in Adults With Hidradenitis Suppurativa
리드: 다케다
- 2상모집 중· Immune Checkpoint Inhibitor-Related ColitisEarly Vedolizumab as First-Line for Immune-Related Colitis Therapy Trial
협력: 다케다
- 2상모집 중· Crohn's DiseaseA Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)
리드: 다케다
- 2상모집 중· Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)A Study of TAK-411 in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
리드: 다케다
- 2상모집 중· Narcolepsy Type 2A Study of TAK-360 in Adults With Narcolepsy Without Cataplexy (NT2)
리드: 다케다
- 2상모집 중· Subarachnoid Hemorrhage, AneurysmalComplement Inhibition: Attacking the Overshooting Inflammation @Fter Subarachnoid Hemorrhage (CIAO@SAH)
협력: 다케다
- 2상모집 중· Celiac DiseaseEvaluating the Efficacy and Tolerability of ZED1227 in Subjects With Non-responsive Celiac Disease
협력: 다케다
- 2상모집 중단 (진행 중)· Gastroesophageal Reflux Disease (GERD)A Study to Check the Safety of Dexlansoprazole and Learn if it Can Treat Symptomatic Nonerosive Gastroesophageal Reflux Disease in Children 2 to 11 Years Old
리드: 다케다
- 2상모집 중· MyelofibrosisA Study of Elritercept Alone or Together With Ruxolitinib in Adults With Myelofibrosis
리드: 다케다
- 2상모집 중단 (진행 중)· Relapsed or Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)A Study of TAK-007 in Adults With Relapsed or Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)
리드: 다케다
- 2상모집 중단 (진행 중)· Myeloma, MultipleStudy of Lenalidomide/Ixazomib/Dexamethasone/Daratumumab in Transplant-Ineligible Patients With Newly Diagnosed MM
협력: 다케다
- 2상모집 중· Myelodysplastic SyndromesA Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS)
리드: 다케다
- 2상모집 중· Neurofibromatosis Type 2Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)
협력: 다케다
- 2상모집 중단 (진행 중)· Plasma Cell MyelomaDaratumumab, Ixazomib, & Dexamethasone or Daratumumab, Bortezomib, & Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma
협력: 다케다
- 2상모집 중단 (진행 중)· Recurrent Plasma Cell MyelomaDaratumumab, Bortezomib, and Dexamethasone Followed by Daratumumab, Ixazomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
협력: 다케다
- 2상모집 중단 (진행 중)· Multiple MyelomaIxazomib Plus Lenalidomide Plus Dexamethasone for Newly Diagnosed Myeloma Patients
협력: 다케다
- 2상모집 중· Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveBlinatumomab, Methotrexate, Cytarabine, and Ponatinib in Treating Patients With Philadelphia Chromosome-Positive, or BCR-ABL Positive, or Relapsed/Refractory, Acute Lymphoblastic Leukemia
협력: 암젠, 다케다
- 2상모집 중단 (진행 중)· Malignant Rhabdoid TumorPhase 2 Study of Alisertib Therapy for Rhabdoid Tumors
협력: 다케다
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.